KYMRInvestorglobenewswire

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

Sentiment:Negative (20)

Summary

WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events:

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 27, 2025 by globenewswire

    Kymera Therapeutics to Participate in Upcoming September Investor Conferences | KYMR Stock News | Candlesense